CLX logo

The Clorox Company Stock Price

NYSE:CLX Community·US$12.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 109 Fair Values set on narratives written by author

CLX Share Price Performance

US$106.69
-12.70 (-10.64%)
US$133.25
Fair Value
US$106.69
-12.70 (-10.64%)
19.9% undervalued intrinsic discount
US$133.25
Fair Value
Price US$106.69
AnalystHighTarget US$133.25
AnalystConsensusTarget US$101.71
AnalystLowTarget US$77.00

CLX Community Narratives

·
Fair Value US$133.25 19.9% undervalued intrinsic discount

Rising Global Health Awareness And ERP Transformation Will Expand Demand

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
·
Fair Value US$101.71 4.9% overvalued intrinsic discount

Analysts Lower Clorox Price Target Amid Service Disruptions and Muted Profit Outlook

0users have liked this narrative
0users have commented on this narrative
41users have followed this narrative
·
Fair Value US$77 38.6% overvalued intrinsic discount

Consumer Shifts And Rising Compliance Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$133.25
19.9% undervalued intrinsic discount
Revenue
6.78% p.a.
Profit Margin
10.93%
Future PE
21.49x
Price in 2029
US$163.15
US$101.71
4.9% overvalued intrinsic discount
Revenue
6.12% p.a.
Profit Margin
10.85%
Future PE
17.13x
Price in 2029
US$125.29
US$77
38.6% overvalued intrinsic discount
Revenue
5.38% p.a.
Profit Margin
10.12%
Future PE
13.71x
Price in 2029
US$93.93

Trending Discussion

No trending discussion available.

Updated Narratives

CLX logo

CLX: GOJO Integration And ERP Gains Will Support Long Term Earnings

Fair Value: US$133.25 19.9% undervalued intrinsic discount
7 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLX logo

CLX: GOJO Deal And Leadership Transition Will Shape Healthcare Portfolio Outlook

Fair Value: US$101.71 4.9% overvalued intrinsic discount
41 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLX logo

CLX: Mounting Execution Risks Around GOJO Integration Will Pressure Future Earnings Power

Fair Value: US$77 38.6% overvalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Average dividend payer and slightly overvalued.

2 Risks
2 Rewards

The Clorox Company Key Details

US$6.7b

Revenue

US$3.9b

Cost of Revenue

US$2.8b

Gross Profit

US$2.3b

Other Expenses

US$587.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
4.85
42.32%
8.74%
2,011.1%
View Full Analysis

About CLX

Founded
1913
Employees
9200
CEO
Linda Rendle
WebsiteView website
www.thecloroxcompany.com

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Clean brands; and dressings, dips, seasonings, sauces, water-filtration products, and natural personal care products under the Brita and Burt’s Bees brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; distributors; and other retail outlets through direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Recent CLX News & Updates

Seeking Alpha Aug 21

Clorox: A Better Business, But Too Much Growth Is Priced In

Summary I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns. Despite optimism around wellness trends, I see an insufficient margin of safety at current prices and recommend monitoring for a significant price drop. Read the full article on Seeking Alpha
Narrative Update Aug 21

CLX: GOJO Integration And ERP Gains Will Support Long Term Earnings

The updated analyst price target for Clorox has shifted lower by about $8 per share, with analysts pointing to wider uncertainty around FY27 earnings, softer recent share trends and the potential for increased reinvestment under new leadership as key factors. Analyst Commentary Recent Street research on Clorox shows a mix of caution and optimism, with several bullish analysts lifting price targets even as others trim expectations on longer term earnings guidance.

Recent updates

No updates